Peptides linked to performance or image enhancement such as growth hormone releasing peptides (GHRPs), growth hormone releasing peptide-6 (GHRP-6), and pralmorelin (GHRP-2) are Schedule 4 prescription-only medicines, as per the Poisons Standard
eLife 8 , e48630 (2019)
Cardioprotection and Organ Protection GH secretagogues including synthetic GHRPs have demonstrated cardioprotective effects in ischemic heart models
Two pathways are especially important in IGF-1 receptor research: PI3K/Akt/mTOR pathway MAPK/ERK pathway The PI3K/Akt/mTOR pathway is often discussed in relation to protein synthesis marker research, survival signalling, nutrient response markers and cellular growth models
AOD-9604 is a synthetic peptide that models the C-terminal lipolytic domain of human growth hormone (residues 176191) with an added N-terminal tyrosine
NAD+ and Skin: Cellular Energy, DNA Repair, and Collagen Maintenance NAD+ (nicotinamide adenine dinucleotide) is not a peptide in the conventional sense, but its included in peptide therapy protocols for skin rejuvenation because it addresses one of the most upstream causes of skin aging
